~45 spots leftby Dec 2027

Varied Sleep Patterns for Cardiometabolic Health

Recruiting in Palo Alto (17 mi)
MS
Overseen byMarie-Pierre St-Onge, PhD
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Columbia University
Must not be taking: Beta-blockers, Anti-coagulants, Anti-platelets
Disqualifiers: Sleep disorders, Psychiatric disorders, Diabetes, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to test the impact of repeated intermittent short sleep, with short sleep maintained 5 days per week followed by 2 days of prolonged sleep, compared to daily adequate sleep, on energy balance and cardiometabolic risk. A secondary goal of this research is to determine if maintaining a constant midpoint of sleep while undergoing intermittent short sleep, leads to better outcomes than intermittent short sleep with a 2-hour delay in sleep midpoint. The aims of this research will be tested in the context of a 3-group, parallel-arm, outpatient intervention of 4 weeks in duration, in young-to-middle-aged adults (aged 18-49 years).

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking beta-blockers, anti-coagulants, or anti-platelets.

What data supports the effectiveness of the treatment Varied Sleep Patterns for Cardiometabolic Health?

Research shows that irregular sleep patterns, like social jetlag, are linked to higher risks of obesity, diabetes, and heart issues. Regular and adequate sleep can help reduce these risks by improving metabolic health.12345

Is varied sleep pattern treatment safe for humans?

Research on varied sleep patterns, like social jetlag, suggests it may be linked to higher body weight and cardiometabolic risks, such as obesity and poor nutrient intake. However, these studies focus on associations rather than direct safety evaluations, so more research is needed to fully understand the safety of these sleep patterns.16789

How does the treatment of Intermittent Short Sleep (ISS) and Social Jetlag (SJL) differ from other treatments for cardiometabolic health?

This treatment is unique because it focuses on managing sleep patterns, specifically the timing and duration of sleep, to address cardiometabolic health. Unlike traditional treatments that might focus on medication or diet, this approach targets the circadian rhythm (the body's internal clock) and its impact on metabolism, which is a novel way to address issues like obesity and diabetes.1261011

Research Team

MS

Marie-Pierre St-Onge, PhD

Principal Investigator

Columbia University

Eligibility Criteria

This trial is for adults aged 18-49 with a BMI of 20-29.9 who usually sleep 7-9 hours without aids or naps. It's not for those who've recently changed weight, are in weight loss programs, have had bariatric surgery, smoke, have sleep disorders, take certain blood medications, have psychiatric conditions including eating disorders and seasonal affective disorder, are pregnant or breastfeeding, have high blood pressure on beta-blockers or diabetes.

Inclusion Criteria

I usually sleep 7-9 hours a night without needing sleeping pills or naps.
Your body mass index (BMI) is between 20 and 29.9.
I am between 18 and 49 years old.

Exclusion Criteria

You frequently travel to different time zones, or work non-traditional hours such as night shifts.
I am currently taking blood thinners.
I have recently changed my weight, joined a weight loss program, or had weight loss surgery.
See 7 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants undergo a 3-group, parallel-arm, outpatient intervention to test the impact of sleep patterns on cardiometabolic health

4 weeks
Weekly visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the intervention

4 weeks

Treatment Details

Interventions

  • Intermittent Short Sleep (ISS) (Behavioral Intervention)
  • Social Jetlag (SJL) (Behavioral Intervention)
  • Sustained Adequate Sleep (SAS) (Behavioral Intervention)
Trial OverviewThe study compares the effects of intermittent short sleep (5 days of less sleep followed by 2 days of more) to consistent adequate nightly sleep on heart health and metabolism over an eight-week period. It also examines if keeping a constant midpoint of sleep during short nights affects outcomes differently than shifting it later.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: ISS_SJLExperimental Treatment2 Interventions
Intermittent short sleep with short jetlag (SJL) 5 nights of 5.5 hours time in bed 2 nights of 9.5 hours time in bed with constant bedtimes and delayed wake times
Group II: ISS_AloneExperimental Treatment1 Intervention
Intermittent short sleep (ISS) 5 nights of 5.5 hours time in bed 2 nights of 9.5 hours time in bed with advanced bedtimes and delayed wake times
Group III: Stable Adequate Sleep (SAS)Active Control1 Intervention
Participants will go to bed and wake up at the same time every night, maintaining adequate sleep duration.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+
Dr. Katrina Armstrong profile image

Dr. Katrina Armstrong

Columbia University

Chief Executive Officer

MD from Johns Hopkins University, MS in Epidemiology from Harvard School of Public Health

Dr. Katrina Armstrong profile image

Dr. Katrina Armstrong

Columbia University

Chief Medical Officer

MD from Harvard Medical School

Icahn School of Medicine at Mount Sinai

Collaborator

Trials
933
Recruited
579,000+
Dr. Brendan Carr profile image

Dr. Brendan Carr

Icahn School of Medicine at Mount Sinai

Chief Executive Officer since 2024

MD, MA, MS

Dr. Vicki LoPachin profile image

Dr. Vicki LoPachin

Icahn School of Medicine at Mount Sinai

Chief Medical Officer

MD, FACP, MBA

University of Colorado, Denver

Collaborator

Trials
1,842
Recruited
3,028,000+
Aviva Abosch profile image

Aviva Abosch

University of Colorado, Denver

Chief Medical Officer since 2019

MD

Uday B. Kompella profile image

Uday B. Kompella

University of Colorado, Denver

Chief Executive Officer since 2015

PhD in Pharmaceutical Sciences

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+
Dr. Gary H. Gibbons profile image

Dr. Gary H. Gibbons

National Heart, Lung, and Blood Institute (NHLBI)

Chief Executive Officer since 2012

MD from Harvard Medical School

Dr. James P. Kiley profile image

Dr. James P. Kiley

National Heart, Lung, and Blood Institute (NHLBI)

Chief Medical Officer since 2011

MD from University of California, San Francisco

Findings from Research

In a study of 1,208 Hispanic youth aged 8-16, social jetlag (the difference in sleep timing between weekdays and weekends) was linked to healthier behaviors, including more physical activity and a higher healthy eating index, as well as lower odds of being overweight.
Conversely, shorter sleep duration was associated with less physical activity but did not show a significant relationship with other cardiometabolic outcomes, suggesting that sleep timing may be more critical for health than total sleep duration.
Associations of sleep duration and social jetlag with cardiometabolic risk factors in the study of Latino youth.Johnson, DA., Reid, M., Vu, TT., et al.[2021]
In a study of 145 healthy participants, those with 2 or more hours of social jetlag exhibited higher cortisol levels, less sleep during the week, and increased resting heart rates compared to those with 1 hour or less of social jetlag.
The findings suggest that social jetlag is linked to negative endocrine, behavioral, and cardiovascular risk factors, potentially increasing the risk for metabolic diseases and mental health issues like diabetes and depression.
Is social jetlag associated with an adverse endocrine, behavioral, and cardiovascular risk profile?Rutters, F., Lemmens, SG., Adam, TC., et al.[2014]
In a study of 792 patients with non-communicable chronic diseases, social jetlag was found to be positively associated with higher fasting glucose levels, indicating a potential link to metabolic complications.
Patients experiencing social jetlag of more than 1 hour had double the odds of being overweight and 1.8 times the odds of being metabolically unhealthy obese, suggesting that disrupted circadian rhythms may increase the risk of obesity and related health issues.
Social jetlag and metabolic control in non-communicable chronic diseases: a study addressing different obesity statuses.Mota, MC., Silva, CM., Balieiro, LCT., et al.[2019]

References

Associations of sleep duration and social jetlag with cardiometabolic risk factors in the study of Latino youth. [2021]
Irregular sleep and cardiometabolic risk: Clinical evidence and mechanisms. [2023]
Is social jetlag associated with an adverse endocrine, behavioral, and cardiovascular risk profile? [2014]
Social jetlag and metabolic control in non-communicable chronic diseases: a study addressing different obesity statuses. [2019]
Associations of chronotype and sleep patterns with metabolic syndrome in the Hispanic community health study/study of Latinos. [2023]
Association of social jetlag with metabolic syndrome among Japanese working population: the Furukawa Nutrition and Health Study. [2022]
Persistent, High Levels of Social Jetlag Predict Poor Weight Outcomes in a Weight Gain Prevention Study for Young adults. [2023]
Short sleep and social jetlag are associated with higher intakes of non-milk extrinsic sugars, and social jetlag is associated with lower fibre intakes in those with adequate sleep duration: a cross-sectional analysis from the National Diet and Nutrition Survey Rolling Programme (Years 1-9). [2023]
Social jetlag and obesity. [2022]
Cardiometabolic risk factors and social jetlag in university professors. [2023]
The association between metabolic parameters and evening chronotype and social jetlag in non-shift workers: A meta-analysis. [2022]